Company’s web-based platform empowers researchers to integrate, process, and visualize biological data in one place, shortening timelines from experiment to results SAN FRANCISCO–LatchBio, a company accelerating the pace of scientific progress by enabling researchers to store and analyze data without touching code or cloud infrastructure, today announced a $28 million Series A round co-led by […]
Emerges from Stealth with $600 Million in Funding NEWARK, California – Today Ultima Genomics emerged from stealth mode with a new high-throughput, low-cost sequencing platform that delivers the $100 genome. Ultima’s goal is to unleash a new era in genomics-driven research and healthcare, and it has secured approximately $600 million in backing from leading investors […]
Financing Led by Medical Excellence Capital and Alexandria Venture Investments Gregory T. Lucier joins Pleno as Chairman of the Board of Directors SAN DIEGO — Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced the close of $15 million in Pre-Series A financing led by experienced life […]
New funding will be used to advance Ionpath’s MIBI technology in translational research and precision medicine MENLO PARK, Calif. — Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being […]
600% revenue growth rate, Sequentify supplies Next Generation Sequencing libraries and software for cancer diagnostics, carrier screening and COVID-19 surveillance REHOVOT, Israel — Sequentify, a Weizmann Institute of Science spinoff, enables fast and focused DNA sequencing. It combines tools from the synthetic biology and AI software fields to enable rapid targeted DNA sequencing. Sequentify exits […]
BOSTON & MUMBAI, India — TA Associates (“TA”), a leading global growth private equity firm, today announced that the firm has completed a strategic growth investment in Zifo RnD Solutions (“Zifo”), a leading provider of scientific informatics services. Founded in 2008, Zifo helps enable the digital transformation of Drug Discovery, Clinical Development, Manufacturing Quality Control […]
IPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTs™ with 3D protein structure and function DIEPENBEEK, Belgium — Diepe IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to share that IPA’s subsidiary Biostrand, a Belgian end-to-end multi-omics analysis platform provider, has received a €460,000 round of […]
Funding round includes investments from Purdue Foundry and Elevate Ventures WEST LAFAYETTE, Ind. – Novilytic LLC, a biochemistry analytics company that protects and secures lifesaving drugs, has completed a $1.6 million seed round in addition to its $1.4 million National Institutes of Health Small Business Innovation Research grant. The seed round investments include contributions from […]
RIEHEN, Switzerland — Bionter AG, experts in sub-visible particle testing, announced the completion of a $3 million Series Seed financing from Dynamk Capital. Bionter revolutionizes analytical testing of subvisible particles in the biopharmaceutical industry in respect to economy, process time and safety. Proceeds from this round will help the company to expand their committed team, launch […]
IRVINE, Calif. — Zymo Research and Star Array today announced Zymo Research’s strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore. The investment allows Zymo Research and Star Array to combine Zymo Research’s nucleic acid purification and assay technologies with Star Array’s engineering and automation expertise to expand into […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
